- Home
- ATLC vs JSPRW Comparison
ATLC vs JSPRW Comparison
Compare ATLC & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLC
- JSPRW
- Stock Information
- Founded
- ATLC 1996
- JSPRW N/A
- Country
- ATLC United States
- JSPRW United States
- Employees
- ATLC N/A
- JSPRW N/A
- Industry
- ATLC Finance: Consumer Services
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- ATLC Finance
- JSPRW Health Care
- Exchange
- ATLC Nasdaq
- JSPRW Nasdaq
- Market Cap
- ATLC N/A
- JSPRW N/A
- IPO Year
- ATLC 1999
- JSPRW N/A
- Fundamental
- Price
- ATLC $57.27
- JSPRW $0.12
- Analyst Decision
- ATLC Strong Buy
- JSPRW
- Analyst Count
- ATLC 5
- JSPRW 0
- Target Price
- ATLC $57.20
- JSPRW N/A
- AVG Volume (30 Days)
- ATLC 62.9K
- JSPRW 7.8K
- Earning Date
- ATLC 03-03-2025
- JSPRW 03-05-2025
- Dividend Yield
- ATLC N/A
- JSPRW N/A
- EPS Growth
- ATLC 8.45
- JSPRW N/A
- EPS
- ATLC 4.45
- JSPRW N/A
- Revenue
- ATLC $374,090,000.00
- JSPRW N/A
- Revenue This Year
- ATLC N/A
- JSPRW N/A
- Revenue Next Year
- ATLC $12.99
- JSPRW N/A
- P/E Ratio
- ATLC $12.87
- JSPRW N/A
- Revenue Growth
- ATLC 8.50
- JSPRW N/A
- 52 Week Low
- ATLC $23.10
- JSPRW $0.15
- 52 Week High
- ATLC $64.70
- JSPRW $0.16
- Technical
- Relative Strength Index (RSI)
- ATLC 45.78
- JSPRW N/A
- Support Level
- ATLC $57.40
- JSPRW N/A
- Resistance Level
- ATLC $63.00
- JSPRW N/A
- Average True Range (ATR)
- ATLC 2.26
- JSPRW 0.00
- MACD
- ATLC -0.01
- JSPRW 0.00
- Stochastic Oscillator
- ATLC 25.58
- JSPRW 0.00
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.